Evidence map›Paper›PMID 37760099›Full record

ArticleBioengineering (Basel, Switzerland)2023

Optimizing Bioink Composition for Human Chondrocyte Expression of Lubricin.

Kari Martyniak, Sean Kennedy, Makan Karimzadeh, Maria A Cruz, Oju Jeon, Eben Alsberg, Thomas J Kean

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kari MartyniakBiionix Cluster, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Sean KennedyBiionix Cluster, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Makan KarimzadehBiionix Cluster, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Maria A CruzBiionix Cluster, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.
Oju JeonDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0003-3972-9272
Eben AlsbergDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0002-3487-4625
Thomas J KeanBiionix Cluster, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.ORCID 0000-0001-6844-3404
University of Central Florida · USUniversity of Illinois Chicago · US

Funding

University of Central Florida StartupUniversity of Central Florida College of Medicine Startup
6 · The paper itself

Abstract

The surface zone of articular cartilage is the first area impacted by cartilage defects, commonly resulting in osteoarthritis. Chondrocytes in the surface zone of articular cartilage synthesize and secrete lubricin, a proteoglycan that functions as a lubricant protecting the deeper layers from shear stress. Notably, 3D bioprinting is a tissue engineering technique that uses cells encapsulated in biomaterials to fabricate 3D constructs. Gelatin methacrylate (GelMA) is a frequently used biomaterial for 3D bioprinting cartilage. Oxidized methacrylated alginate (OMA) is a chemically modified alginate designed for its tunable degradation rate and mechanical properties. To determine an optimal combination of GelMA and OMA for lubricin expression, we used our novel high-throughput human articular chondrocyte reporter system. Primary human chondrocytes were transduced with

Indexed as

3D bioprinting cartilageengineered extracellular matrix reporterhuman articular chondrocyte reporterlap-shearlubricin chondrocyte reporteroxidized methacrylated alginatesurface zone articular cartilagetissue engineered cartilage

Identifiers

PMID37760099
PMCPMC10526043
OpenAlexW4386096375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.